CompagOs
Our mission is to help oncologists select the most effective treatment for patients with cancer in the bone. Leveraging 3D bioprinting technology, we recreate the unique cancerous condition of the patient's bone in a controlled laboratory environment, enabling us to assess different drug reactions and determine personalized treatment options. By surpassing the limitations of conventional animal and 2D models, we also envision our solution as a powerful tool for drug development, accurately reproducing human physiological conditions and driving innovation in the field. Together, we aim to revolutionize cancer treatment by offering personalized solutions that improve patient outcomes and advance the field of oncology.
Tech Stack (6 technologies)
Frequently Asked Questions
What technologies does CompagOs use?+
CompagOs uses 6 technologies including Next.js, Umami, React.
What industry is CompagOs in?+
CompagOs operates in the Oncology industry.
Where is CompagOs based?+
CompagOs is headquartered in Switzerland.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026